Log In

Forgot Password?


Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

Abstract Details

Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome
Multiple Sclerosis
S31 - MS Clinical Decision Making and Special Populations (5:06 PM-5:18 PM)

Okuda et al. introduced the RIS criteria for the first time in 2009. In 2018, the MAGNIMS group proposed less stringent criteria. There are no studies comparing these two criteria.

This study aimed to analyze the factors that predict the conversion of radiologically isolated syndrome (RIS) patients to multiple sclerosis (MS), and the validity of the two RIS diagnostic criteria.

All participants with suspected demyelinating brain MRI lesions were included in this study. Patient data was collected including demographics, clinical and cerebrospinal fluid (CSF) parameters, and MRI lesion characteristics. All MRI images were reevaluated by two MS specialists and a neuroradiologist. Multi-parameter Cox-regression method was used during the analyses.

A total of 130 patients (30 mRIS, 65 Okuda and mRIS, 35 nonRIS) from seven centers were included into the study. Fifty percent of the patients converted into MS after 8.59 years (95% CI: 3.95-13.22). The conversion rate of the three groups were comparable (p=0.18). Presence of oligoclonal bands in the CSF (OCB) (HR=0.09, p=0.02), elevated IgG index (HR=0.08, p=0.02), and presence of spinal MRI lesion (HR= 0.23, p=0.001) predicted conversion to MS. Male gender (HR=1.05, p=0.89) and age less than 37 (HR=0.56, p=0.21) were not predictive of conversion to MS.

Our findings indicates that baseline spinal lesions, an elevated IgG index, and OCB are the best predictors of conversion to MS. Considering conversion to MS, we found no difference between patients who fulfilled the Okuda or modified RIS criteria. It is necessary to explore new parameters that will improve the sensitivity and specificity of the present diagnostic criteria for RIS.

Dr. Gunduz has nothing to disclose.
Irem Ciftci (Istanbul Medical Faculty) Dr. Ciftci has nothing to disclose.
Bilge Piri Cinar No disclosure on file
Cavid Baba, MD Mr. Baba has nothing to disclose.
Meral Seferoglu No disclosure on file
Ali Ozhan Sivaci, Sr., MD (BURSA YUKSEK IHTISAS EGITIM VE ARASTIRMA HASTANESI) Dr. SIVACI has nothing to disclose.
Vedat Cilingir, MD (Van yüzüncü yil üniversitesi) Dr. Cilingir has nothing to disclose.
Ozlem Ethemoglu ÖZLEM ETHEMOGLU has nothing to disclose.
Levent Ocek LEVENT OCEK, 4284 has nothing to disclose.
Mehmet Barburoglu, Sr., MD Dr. Barburoglu has nothing to disclose.
Serkan Ozakbas, MD (DOKUZ EYLUL UNI. FACULTY OF MEDICINE) Dr. Ozakbas has nothing to disclose.
Mefkure Eraksoy, MD (ISTANBUL UNIVERSITY) Dr. Eraksoy has nothing to disclose.
Murat Kurtuncu, MD (Istanbul University) Dr. Kurtuncu has nothing to disclose.